OncBioMune Pharmaceuticals, Inc 4/A
4/A · OncBioMune Pharmaceuticals, Inc · Filed Apr 20, 2017
Insider Transaction Report
Form 4/AAmended
HEAD JONATHAN FREDERICK
DirectorChief Executive Officer
Transactions
- Other
Series B Preferred Stock
2017-03-10+2,892,000→ 2,892,000 total - Award
Employee Stock Option (right to buy)
2017-03-10+2,000,000→ 2,000,000 totalExercise: $0.25Exp: 2027-03-10→ Common Stock (2,000,000 underlying)
Footnotes (3)
- [F1]Securities issued pursuant to the terms and conditions of a Contribution Agreement to the Property of Trust F/2868 entered into among OncBioMune Pharmaceuticals, Inc., Manuel Cosme Odabachian and Carlos Fernando Alaman Volnie dated March 10, 2017 as filed by the Issuer as Exhibit 10.1 to its Current Report on Form 8-K as filed with the SEC on March 13, 2017.
- [F2]Amended to include stock option award.
- [F3]One-third of the Stock Options vest on March 10, 2018, March 10, 2019 and March 10, 2020.